Skip to content

HELX FRANKLIN TEMPLETON ETF TR

Follow

GENOMIC ADV ETF (fund)

6 managers (6 13F filers) reported a position in HELX shares at 2025-09-30, 14,268 shares in all. 0 filers opened a position and 3 filers sold out during the quarter.

Managers
6
13F filers
6
New
0
Added
0
Reduced
2
Sold out
3
Shares held by filers
14,268

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2025

Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
LPL Financial LLC9,096$282K<0.01%-12,58413F-HRTimeline
OSAIC HOLDINGS, INC.in group OSAIC HOLDINGS, INC.3,132$95.5K<0.01%013F-HRTimelineGroup
HARBOUR INVESTMENTS, INC.1,637$49.9K<0.01%-5013F-HRTimeline
HALBERT HARGROVE GLOBAL ADVISORS, LLC402$12.4K<0.01%013F-HRTimeline
MORGAN STANLEYin group MORGAN STANLEY1$50<0.01%013F-HR/ATimelineGroup
JPMORGAN CHASE & COin group JPMORGAN CHASE & CO0$1<0.01%013F-HR/ATimelineGroupAmount filed as zero, left out of ratios.